MarketPulse

commercial revenue

3 articles
The Motley FoolThe Motley Fool··Keithen Drury

Palantir's AI Boom Masks Stretched Valuation: Can Growth Justify 108x Multiple?

Palantir's commercial revenue surges 137% YoY amid AI gains, yet 108x forward earnings multiple demands tripling earnings in 3-5 years to justify valuation.
PLTRvaluationartificial intelligence
The Motley FoolThe Motley Fool··David Jagielski, Cpa

Palantir's 127% Rule of 40 Score Masks Extreme 200x Earnings Valuation Risk

Palantir posts 127% Rule of 40 score and 70% growth, but trades at 200x earnings with $330B market cap on $5B revenue, leaving no valuation margin of safety.
PLTRvaluationartificial intelligence
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lifecore Biomedical Lands Third Commercial Site Transfer in Medical Aesthetics Push

Lifecore Biomedical announces third commercial CDMO site transfer since October 2025, targeting 12% revenue CAGR through 2029.
LFCRCDMOcontract manufacturing